Ivermectin becomes available over the counter amid safety concerns

In recent weeks, three states in the United States have authorized the sale of ivermectin over the counter. This medication is primarily used to treat specific parasitic worm infections in humans, namely intestinal strongyloidiasis and onchocerciasis. Each of these conditions poses health risks, and ivermectin is considered effective only for these approved uses. However, there is a growing trend among some individuals advocating for ivermectin’s use beyond these conditions. They argue that high levels of the medication could have an impact on the coronavirus, despite no conclusive clinical evidence supporting its effectiveness against COVID-19. This belief has resulted in increased demand for the drug in forms not regulated or approved for public use. Federal health officials have expressed concern over the potential harms associated with taking ivermectin, especially when sourced from veterinary formulations intended for animal consumption. The risks include severe digestive, respiratory, and skin problems, and even life-threatening conditions for immunocompromised individuals. Despite ongoing warnings, the push to make ivermectin more accessible continues, raising questions about safety, approvals, and the importance of using medications only as intended and advised by healthcare professionals. As more states permit over-the-counter access, the discourse surrounding ivermectin is likely to deepen, emphasizing the need for responsible guidance in its use.